Plasmids with mutations in tifA, the gene encoding the replication initiation protein of the broad-host-range plasmid RK2, were isolated and characterized. Mutants identified from a nitrosoguanidine bank were defective in supporting the replication of a wild-type RK2 origin in Escherichia coli. Most of the mutations were clustered in a region of tifA corresponding to the carboxy-terminal quarter of the TrfA protein. 5' and 3' deletion mutants of trfA were also constructed. A C-terminal deletion of three amino acids of the Tr A protein was completely nonfunctional for RK2 replication. However, a deletion of 25 amino acids from the start of the 33-kDa TrfA protein was still competent for replication. Further characterization of the point and deletion trfA mutants in vivo revealed that a subset was capable of supporting RK2 replication in other gram-negative bacteria, including Pseudononas putida, Agrobacterium tumefaciens, and Azotobacter vinelandii. Selected mutant TrfA proteins were partially purified and characterized in vitro. Velocity sedimentation analysis of these partially purified TrfA proteins indicated that the wild-type protein and all mutant TrfA proteins examined exist as dimers in solution. Results from in vitro replication assays corroborated the experimental findings in vivo. Gel retardation results clearly indicated that the point mutant TrfA-33:151S, which was completely defective in replication of an RK2 origin in all of the bacterial hosts tested in vivo, and a carboxy-terminal deletion mutant, TrfA-33:CA305, were not able to bind iterons in vitro. In addition to the proteins from mutants that were totally defective in DNA binding, several other mutant proteins were either partially defective or could not be distinguished from the wild-type protein in binding to the origin region. The mutant proteins with apparently normal DNA-binding activity in vitro either were inactive in all four gram-negative bacteria tested or exhibited differences in functionality depending on the host organism. These mutant TrfA proteins may be altered in the ability to interact with the replication proteins of the specific host bacterium.
RK2 is a 60-kb self-transmissible plasmid that can be stably maintained in a wide variety of gram-negative hosts (9, 21, 27, 32, 33, 40) . It is a member of the IncP1 incompatibility group, and the number of copies of RK2 in Escherichia coli has been estimated as four to seven per chromosome (17) . Two plasmid elements that are essential for RK2 plasmid replication are the cis-acting origin of replication, oriV, and the trans-acting replication initiation protein, TrfA (16, 47, 50, 51) . The origin of replication was originally defined as a 700-bp HaeII fragment. In addition to eight 17-bp direct repeats, or iterons, arranged in two clusters of five and three, the origin contains an A+T-and G+C-rich region and sequences homologous to DnaA boxes (43) . In E. coli, a 393-bp HpaII fragment containing the five-iteron cluster, three of the putative DnaA boxes, and the A+T-and G+C-rich region is also a functional origin. However, the deletion of the upstream cluster of three iterons results in an increase in the number of copies of RK2 derivatives in E.
coli (39, 48, 51) . The trfA gene encodes two polypeptides in the same reading frame, a 44-kDa protein (TrfA-44) and a 33-kDa protein (TrfA-33); TrfA-33 is the product of an internal translational start (24, 41, 42) . Either TrfA-44 or TrfA-33 alone is sufficient for replication in many hosts, including E. coli. However, in Pseudomonas aeruginosa, there is a specific requirement for TrfA-44 in the stable maintenance of the RK2 replicon (11, 15) . TrfA protein can * Corresponding author. be supplied in cis or in trans to an RK2 origin plasmid and initiates replication presumably by binding to the iterons (36, 37) .
To better understand RK2 replication and control, different classes of TrfA mutants have been isolated and characterized. Genetic and biochemical studies on TrfA copy-up mutants, mutants of TrfA that increase the copy number of RK2 replicons in vivo, support a model for the replication control of RK2 involving the intermolecular coupling of TrfA-bound iterons (13, 23) . This model was first proposed for the iteron-containing plasmid R6K (29, 34) . In addition, mutant trfA genes that are temperature sensitive for RK2 replication have also been examined in vivo (49, 53) . In this paper, we present the results of genetic and biochemical studies involving a number of TrfA mutants that are altered in their ability to support RK2 replication. Deletion analyses clearly indicate that the carboxy terminus of the 33-kDa TrfA protein is much more sensitive than the amino terminus to alteration. Furthermore, a trfA mutation that results in total loss of binding to the iterons at the RK2 origin also causes loss of functionality in vivo in three different gramnegative hosts in addition to E. coli. Finally, TrfA mutants that had no apparent loss of DNA binding activity but were either defective in all four bacterial hosts or showed an altered host range were isolated. The properties of these mutants confirm some of the proposed functions of the TrfA initiation protein and offer insight into the mechanism of TrfA function in the initiation of RK2 replication. TrfA-CA305 and TrfA-NA180, generated on vectors conferring penicillin resistance, were tested with pSV16 on LB plates containing kanamycin (50 ,ug/ml). RK2 replication in cis was determined by using the vector pJL4-44/33. pJL4-44/33 and its mutant derivatives were transformed into E. coli C2110 (polA), forcing the vectors to rely on only the RK2 origin. Once again, transformants were selected on LB-agar plates containing penicillin (200 and 100 pg/ml). Analysis of TrfA mutants in other gram-negative organisms. pJL4-44/33 and its mutant derivatives were moved into Azotobacter vinelandii and Agrobacterium tumefaciens by triparental mating with pRK2013 as the source of RK2 transfer genes as described by Schmidhauser and Helinski (40) . Exconjugants were selected with nalidixic acid (20 pg/ml) and carbenicillin (1,000 ,g/ml) in YEP medium (1% peptone, 1% yeast extract, 0.5% NaCl) forA. tumefaciens or carbenicillin (50 ,ug/ml) in Burk medium (31) (23) . Gel mobility shift experiments were performed as described previously (36) , except that the concentration of the nonspecific DNA competitor poly(dIdC) in the binding buffer was increased to 50 ,ug/ml and EDTA was used at 0.1 mM. Mutants were also tested for their ability to bind RK2 iterons in vivo with the vector system of Elledge et al. (14) modified for the RK2 system (52) .
Sucrose gradient analysis of TrfA proteins. Protein preparations containing 30 to 50 ,ug of TrfA were analyzed in 4.8-ml 5 to 15% (wt/wt) sucrose gradients. Sucrose solutions were made in a buffer containing 50 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH 8.0), 50 Mutants are named for the codon changed and the change incurred, except in the cases of 360DUP, which contains an insertion of three amino acids (alanine, cysteine, and glutamic acid), and 363TER, in which an arginine is changed to a stop codon. The deletion mutants are named for the amino acid position at which the TrfA protein begins (N-terminal deletions) or ends (C-terminal deletions). Amino acid residues are numbered from the first methionine of TrfA-44.
The shaded box represents the approximate location of six previously isolated copy-up trfA mutations (13) (2, 20) , and SDS-PAGE (26), were performed as described previously. Western blotting with a semidry horizontal blotting apparatus was done as described by Kyhse-Andersen (25) with a polyvinylidene difluoride membrane (Immobilon-P (Millipore, Bedford, Mass.) instead of nitrocellulose. TrfA was detected with a polyclonal antibody preparation as described previously (12) .
RESULTS
Isolation and mapping of defective TrfA mutants. Plasmids with defective mutations in trfA were from a nitrosoguanidine mutant bank prepared by Durland et al. (13) . The trfA mutant genes were carried on a pBR322-derived plasmid, pRD110-34. E. coli cells carrying individual members of the bank were made competent, transformed with the RK2 origin plasmid pSV16, and plated on LB containing penicillin G or kanamycin. Members of the bank that gave no pSV16 transformants were provisionally considered to be defective in supporting RK2 replication. After an initial screening, 20 of 166 candidates from the 40-min nitrosoguanidine-treated bank were determined to be defective. After clone analyses to confirm that the trfA gene in these mutants was intact and Western blotting with a polyclonal anti-TrfA antibody preparation to determine the size of the mutant protein synthesized (data not shown), a group of mutations producing full-length or near-full-length TrfA proteins was selected for further study. This group included mutations designated l51S, 314S, 329S, 331L, 338C, 360DUP, 361K, and 363TER. All mutations, except 314S, were initially mapped within the trfA gene by performing reciprocal exchanges of restriction fragments between individual mutant and wild-type plasmids, as described by Durland et al. (13) . In the process of mapping mutation 314S, a novel HincII site that was subse--quently determined to be the result of the mutation was identified in the trfA gene. All of the point mutations were sequenced, and the nature of the changes and their locations are shown in Fig. 1 . The trfA mutations are named by designating the number of the codon that was changed and the change incurred with the single-letter amino acid designation. Seven of these eight mutations cluster in the NdeIPstI segment of trfA corresponding to the 3' end of the trfA gene. Only one mutation, 151S, was found to map upstream in the Sfil-HincII region. The mutation 363TER results in a termination codon 20 amino acids before the natural translational stop of trfA and produces a truncated mutant TrfA protein. Additional deletion mutations were generated by using BAL 31 exonuclease (CA379, NA116, NA123), linker insertion (CA305), and simple cloning strategies (NA180) as described in Materials and Methods. These mutations were also sequenced, and the approximate sizes of the resulting protein products are indicated in Fig. 1 deleted. In TrfA-NA180, 82 N-terminal amino acids are deleted.
Properties of trfA mutants in vivo. The functionality of these mutants in vivo was studied in more detail by subcloning them into a variety of plasmid vectors so they could be tested in E. coli in trans (Fig. 2) with respect to an eightiteron (pSV16) or a five-iteron (pBK11) origin plasmid or in cis ( Fig. 3 ) with respect to an eight-iteron RK2 origin (pJL4-44/33) and in other gram-negative organisms ( (Fig. 3) 1 4 5 6 7 8 9 10 proteins. As determined from Coomassie blue-stained gels (Fig. 4A ) and the corresponding Western blots (Fig. 4B) (23) is based on soluble E. coli C600 extracts, which replicate both the five-iteron RK2 plasmid pTJS42 and the eight-iteron RK2 plasmid pTJS26 when purified TrfA protein is added. This system, with the modifications described in the Materials and Methods, was employed to assay the replication activity of mutant TrfA protein preparations. Since some of the mutant preparations were not as pure as TrfA-33, the amount of protein preparation used in the replication assay was such that further addition of protein did not increase activity. The results for templates pTJS26 and pTJS42 ( Iteron-binding properties of TrfA mutants. To study the interaction of mutant TrfA proteins with the RK2 origin of replication in vitro, the gel mobility shift procedure of Perri et al. (36) was used. A 400-bp fragment containing the functional five-iteron HpaII RK2 origin was end labeled and served as the probe. Figures 5A and B show the iteronbinding activities of the mutant TrfA preparations. TrfA-33: 329S, TrfA-NA123, TrfA-NA116, and TrfA-33:361K show strong binding activity with the origin-containing fragment. TrfA-33:329S gives a pattern of complex formation identical to that of the wild type. TrfA-NA116 appears to form complexes that are more distinct than those of as opposed to TrfA-33:361K, which forms less distinct complexes with the probe. TrfA-33:314S, and TrfA-33:338C also demonstrate the ability to shift the origin fragment but not as well as the wild type, TrfA-33, as evidenced by weak complex formation. The binding of these particular mutant preparations to iterons was not improved by the addition of more protein (data not shown). Mutants TrfA-33:151S and TrfA-33:CA305 showed no ability to bind to the iteroncontaining DNA fragment.
A vector system designed by Elledge et al. (14) was adapted for the RK2 system (52) to provide a means to identify TrfA proteins that will bind to two iterons from the RK2 origin in vivo. Binding of TrfA to the two iterons results in the transcriptional repression of a constitutive promoter and allows the expression of the convergent antibiotic resistance gene aadA (spectinomycin). Analyses of the TrfA mutants with this system correlate well with in vitro DNA binding results in that the mutant proteins that bind well in vitro are able to bind in vivo, whereas the mutant protein preparations that are weak in binding are not able to bind in vivo (Table 4) . (46) .
Selected characteristics of all of the mutants are displayed in Table 4 . For most of the mutants described in this study, the nature of the defect is not yet known and can only be inferred. A proposed model (10) TrfA-151S (56) . In previous work, a helix-turn-helix putative DNA-binding domain for TrfA was proposed (42) for a region encompassing the previously identified RK2 "copyup" region ( Fig. 1) (13) . However, according to Brennan and Matthews (5) , the likelihood of the proposed region having the helix-turn-helix DNA-binding motif is low. Computer searches of TrfA with the programs PC/GENE and FASTA (30, 35) 
